# Targeted Chemo-elimination (TCE) of Malaria

> **NCT01872702** · NA · COMPLETED · sponsor: **University of Oxford** · enrollment: 8000 (actual)

## Conditions studied

- Plasmodium Falciparum Malaria

## Interventions

- **DRUG:** malaria elimination using DP and low-dose primaquine

## Key facts

- **NCT ID:** NCT01872702
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 8000 (ACTUAL)
- **Last updated:** 2020-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01872702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01872702, "Targeted Chemo-elimination (TCE) of Malaria". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01872702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*